HempStreet and MGC Pharma launch ArtemiC

HempStreet, in collaboration with MGC Pharma, has launched ‘ArtemiC,’ a nutraceutical mouth spray to speed up recovery for patients with severe COVID-19 symptoms, according to a statement from HempStreet.

The statement said that ArtemiC includes four nature-based ingredients consisting of Curcumin, Boswellia serrata, Artemisinin and Vitamin C. ArtemiC Rescue and ArtemiC Support are the two variations of this product that will be available via medical practitioners and pharmacies.

ArtemiC Rescue is an adjunctive treatment for the symptoms of COVID-19, whereas ArtemiC Support is a daily supplement that does not contain Artemisinin. According to the double-blind, placebo-controlled clinical research findings, ArtemiC may minimise the severity of symptoms of COVID-19. In addition, the clinical trial demonstrated a significant reduction in one of the primary inflammatory markers related to COVID-19, C-Reactive Protein (CRP), an acute inflammatory protein that increases up to 1,000-fold at sites of infection or inflammation, added the statement.

Commenting on the launch, Abhishek Mohan, founder and CEO, HempStreet, said in the statement, “……An observational open-label controlled clinical trial of ArtemiC showed that the formulation demonstrated its efficacy in treating patients with severe COVID-19 for the first time. An estimated 15 million people in India are said to be suffering from “long COVID” symptoms, making it a hidden mass ailment on its own….”